BindingDB logo
myBDB logout

12 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
26181851 26 Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors.EBI Novartis Institutes for BioMedical Research
24601644 113 Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteres.EBI Amgen Inc.
24548297 50 Selective and potent morpholinone inhibitors of the MDM2-p53 protein-protein interaction.EBI Amgen Inc.
22507962 4 The central valine concept provides an entry in a new class of non peptide inhibitors of the p53-MDM2 interaction.EBI Novartis Institutes for BioMedical Research
21277201 35 Synthesis of cell-permeable stapled peptide dual inhibitors of the p53-Mdm2/Mdmx interactions via photoinduced cycloaddition.EBI State University of New York
20638853 12 Functional profiling of p53-binding sites in Hdm2 and Hdmx using a genetic selection system.EBI Purdue University
19880322 56 N-acylpolyamine inhibitors of HDM2 and HDMX binding to p53.BDB NIH